Indefinite Delivery Contract SPE2DR25D7065

Award Date 3/24/25
Last Date to Order 12/31/36
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The Defense Logistics Agency (DLA) Troop Support Medical Supply Chain has awarded an Indefinite Delivery Contract (IDC) valued at $999,999,999 to Amerisourcebergen Drug Corp to provide worldwide pharmaceutical support to various DoD customers. The contract has a 30-month base period and three 30-month option periods, for a total performance period through December 2036. As the prime contractor, Amerisourcebergen will be responsible for furnishing a comprehensive range of pharmaceutical...
The Defense Logistics Agency (DLA) Troop Support Medical Supply Chain has awarded a $999,999,999 Indefinite Delivery Contract (IDC) to Amerisourcebergen Drug Corp to provide worldwide pharmaceutical support to various DoD customers. The contract has a 30-month base period and three 30-month option periods, with an estimated total value of $30.3 billion. The IDC will serve as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical...
The Defense Logistics Agency (DLA) Troop Support Medical Supply Chain has awarded a single-award Indefinite Delivery Contract (IDC) to AmerisourceBergen Drug Corp valued at $999,999,999 through November 2036. This IDC serves as the primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses critical medical commodities including specialty medications, brand-name and generic drugs,...
The Defense Logistics Agency (DLA) Troop Support Medical Supply Chain awarded a single-award Indefinite Delivery Contract (IDC) valued at $999,999,999 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. This IDC, which runs through December 2036, will serve as the primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses critical medical commodities including...
The Defense Logistics Agency (DLA) Troop Support Medical Supply Chain has awarded a single-award Indefinite Delivery Contract (IDC) valued at $9,999,999,999 to Amerisourcebergen Drug Corp to provide worldwide pharmaceutical support to various DoD customers. The contract has a 30-month base period with three 30-month option periods, for a total estimated value of $30.3 billion. This IDC serves as the primary vehicle for Amerisourcebergen to supply a comprehensive range of pharmaceutical...
The Defense Logistics Agency (DLA) Troop Support Medical Supply Chain has awarded an Indefinite Delivery Contract (IDC) valued at $999,999,999 to AmerisourceBergen Drug Corp to provide a comprehensive range of pharmaceutical products and medical supplies in support of military healthcare programs globally. This single-award IDC has a period of performance from September 2025 to December 2036 and serves as a primary vehicle for the DLA to procure critical medical commodities, including...
The Defense Logistics Agency (DLA) Troop Support Medical Supply Chain awarded a single-award Indefinite Delivery Contract (IDC) valued at $999,999,999 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract covers the provision of pharmaceutical products and medical supplies to support military healthcare programs globally. The IDC serves as the primary vehicle for DLA to procure a comprehensive range of medical commodities, including...
The Defense Logistics Agency (DLA) Troop Support Medical Supply Chain has awarded a single-award Indefinite Delivery Contract (IDC) valued up to $999,999,999 to AmerisourceBergen Drug Corp to provide worldwide pharmaceutical and medical supply support. The contract has a 30-month base period and three 30-month option periods, with an estimated total value of $30.3 billion across all awarded regions. This IDC serves as the primary vehicle for supplying a comprehensive range of pharmaceutical...
The Defense Logistics Agency (DLA) Troop Support Medical Supply Chain awarded a single-award Indefinite Delivery Contract (IDC) valued at $9,999,999,999 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which runs through December 2036, will provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The IDC serves as the primary vehicle for DLA to procure...
The Defense Logistics Agency (DLA) Troop Support Medical Supply Chain has awarded an Indefinite Delivery Contract (IDC) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide worldwide pharmaceutical support to various Department of Defense (DoD) customers. The single-award IDC, valued at $999,999,999, will run through December 2026. The contract covers a comprehensive range of pharmaceutical and medical supplies, including specialty medications, brand-name and generic...

The Defense Logistics Agency (DLA) Troop Support Medical Supply Chain has awarded a $999,999,999 Indefinite Delivery Contract (IDC) to Amerisourcebergen Drug Corp to provide worldwide pharmaceutical support to various Department of Defense (DoD) customers. This single-award IDC has a base period of 30 months and three 30-month option periods, for a total potential period of performance through December 2036.

The contract covers a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic areas. Amerisourcebergen will serve as the primary supplier for the North/EUCOM, West/PACOM, South/SOUTHCOM, and Fleet (CONUS/OCONUS) regions, while also providing backup supplier support. This contract diversifies the DoD's access to vital pharmaceuticals and increases resiliency during contingencies or natural disasters. The solicitation was issued as an unrestricted, fully competitive acquisition with a Lowest Price Technically Acceptable (LPTA) evaluation approach.

Generated 6/23/25, 9:42 AM